Cargando…

11β-hydroxysteroid dehydrogenase type 1 deficiency in bone marrow-derived cells reduces atherosclerosis

11β-Hydroxysteroid dehydrogenase type-1 (11β-HSD1) converts inert cortisone into active cortisol, amplifying intracellular glucocorticoid action. 11β-HSD1 deficiency improves cardiovascular risk factors in obesity but exacerbates acute inflammation. To determine the effects of 11β-HSD1 deficiency on...

Descripción completa

Detalles Bibliográficos
Autores principales: Kipari, Tiina, Hadoke, Patrick W. F., Iqbal, Javaid, Man, Tak-Yung, Miller, Eileen, Coutinho, Agnes E., Zhang, Zhenguang, Sullivan, Katie M., Mitic, Tijana, Livingstone, Dawn E. W., Schrecker, Christopher, Samuel, Kay, White, Christopher I., Bouhlel, M. Amine, Chinetti-Gbaguidi, Giulia, Staels, Bart, Andrew, Ruth, Walker, Brian R., Savill, John S., Chapman, Karen E., Seckl, Jonathan R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Federation of American Societies for Experimental Biology 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3606528/
https://www.ncbi.nlm.nih.gov/pubmed/23303209
http://dx.doi.org/10.1096/fj.12-219105
_version_ 1782264027580203008
author Kipari, Tiina
Hadoke, Patrick W. F.
Iqbal, Javaid
Man, Tak-Yung
Miller, Eileen
Coutinho, Agnes E.
Zhang, Zhenguang
Sullivan, Katie M.
Mitic, Tijana
Livingstone, Dawn E. W.
Schrecker, Christopher
Samuel, Kay
White, Christopher I.
Bouhlel, M. Amine
Chinetti-Gbaguidi, Giulia
Staels, Bart
Andrew, Ruth
Walker, Brian R.
Savill, John S.
Chapman, Karen E.
Seckl, Jonathan R.
author_facet Kipari, Tiina
Hadoke, Patrick W. F.
Iqbal, Javaid
Man, Tak-Yung
Miller, Eileen
Coutinho, Agnes E.
Zhang, Zhenguang
Sullivan, Katie M.
Mitic, Tijana
Livingstone, Dawn E. W.
Schrecker, Christopher
Samuel, Kay
White, Christopher I.
Bouhlel, M. Amine
Chinetti-Gbaguidi, Giulia
Staels, Bart
Andrew, Ruth
Walker, Brian R.
Savill, John S.
Chapman, Karen E.
Seckl, Jonathan R.
author_sort Kipari, Tiina
collection PubMed
description 11β-Hydroxysteroid dehydrogenase type-1 (11β-HSD1) converts inert cortisone into active cortisol, amplifying intracellular glucocorticoid action. 11β-HSD1 deficiency improves cardiovascular risk factors in obesity but exacerbates acute inflammation. To determine the effects of 11β-HSD1 deficiency on atherosclerosis and its inflammation, atherosclerosis-prone apolipoprotein E-knockout (ApoE-KO) mice were treated with a selective 11β-HSD1 inhibitor or crossed with 11β-HSD1-KO mice to generate double knockouts (DKOs) and challenged with an atherogenic Western diet. 11β-HSD1 inhibition or deficiency attenuated atherosclerosis (74–76%) without deleterious effects on plaque structure. This occurred without affecting plasma lipids or glucose, suggesting independence from classical metabolic risk factors. KO plaques were not more inflamed and indeed had 36% less T-cell infiltration, associated with 38% reduced circulating monocyte chemoattractant protein-1 (MCP-1) and 36% lower lesional vascular cell adhesion molecule-1 (VCAM-1). Bone marrow (BM) cells are key to the atheroprotection, since transplantation of DKO BM to irradiated ApoE-KO mice reduced atherosclerosis by 51%. 11β-HSD1-null macrophages show 76% enhanced cholesterol ester export. Thus, 11β-HSD1 deficiency reduces atherosclerosis without exaggerated lesional inflammation independent of metabolic risk factors. Selective 11β-HSD1 inhibitors promise novel antiatherosclerosis effects over and above their benefits for metabolic risk factors via effects on BM cells, plausibly macrophages.—Kipari, T., Hadoke, P. W. F., Iqbal, J., Man, T. Y., Miller, E., Coutinho, A. E., Zhang, Z., Sullivan, K. M., Mitic, T., Livingstone, D. E. W., Schrecker, C., Samuel, K., White, C. I., Bouhlel, M. A., Chinetti-Gbaguidi, G., Staels, B., Andrew, R., Walker, B. R., Savill, J. S., Chapman, K. E., Seckl, J. R. 11β-hydroxysteroid dehydrogenase type 1 deficiency in bone marrow-derived cells reduces atherosclerosis.
format Online
Article
Text
id pubmed-3606528
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Federation of American Societies for Experimental Biology
record_format MEDLINE/PubMed
spelling pubmed-36065282013-04-03 11β-hydroxysteroid dehydrogenase type 1 deficiency in bone marrow-derived cells reduces atherosclerosis Kipari, Tiina Hadoke, Patrick W. F. Iqbal, Javaid Man, Tak-Yung Miller, Eileen Coutinho, Agnes E. Zhang, Zhenguang Sullivan, Katie M. Mitic, Tijana Livingstone, Dawn E. W. Schrecker, Christopher Samuel, Kay White, Christopher I. Bouhlel, M. Amine Chinetti-Gbaguidi, Giulia Staels, Bart Andrew, Ruth Walker, Brian R. Savill, John S. Chapman, Karen E. Seckl, Jonathan R. FASEB J Research Communications 11β-Hydroxysteroid dehydrogenase type-1 (11β-HSD1) converts inert cortisone into active cortisol, amplifying intracellular glucocorticoid action. 11β-HSD1 deficiency improves cardiovascular risk factors in obesity but exacerbates acute inflammation. To determine the effects of 11β-HSD1 deficiency on atherosclerosis and its inflammation, atherosclerosis-prone apolipoprotein E-knockout (ApoE-KO) mice were treated with a selective 11β-HSD1 inhibitor or crossed with 11β-HSD1-KO mice to generate double knockouts (DKOs) and challenged with an atherogenic Western diet. 11β-HSD1 inhibition or deficiency attenuated atherosclerosis (74–76%) without deleterious effects on plaque structure. This occurred without affecting plasma lipids or glucose, suggesting independence from classical metabolic risk factors. KO plaques were not more inflamed and indeed had 36% less T-cell infiltration, associated with 38% reduced circulating monocyte chemoattractant protein-1 (MCP-1) and 36% lower lesional vascular cell adhesion molecule-1 (VCAM-1). Bone marrow (BM) cells are key to the atheroprotection, since transplantation of DKO BM to irradiated ApoE-KO mice reduced atherosclerosis by 51%. 11β-HSD1-null macrophages show 76% enhanced cholesterol ester export. Thus, 11β-HSD1 deficiency reduces atherosclerosis without exaggerated lesional inflammation independent of metabolic risk factors. Selective 11β-HSD1 inhibitors promise novel antiatherosclerosis effects over and above their benefits for metabolic risk factors via effects on BM cells, plausibly macrophages.—Kipari, T., Hadoke, P. W. F., Iqbal, J., Man, T. Y., Miller, E., Coutinho, A. E., Zhang, Z., Sullivan, K. M., Mitic, T., Livingstone, D. E. W., Schrecker, C., Samuel, K., White, C. I., Bouhlel, M. A., Chinetti-Gbaguidi, G., Staels, B., Andrew, R., Walker, B. R., Savill, J. S., Chapman, K. E., Seckl, J. R. 11β-hydroxysteroid dehydrogenase type 1 deficiency in bone marrow-derived cells reduces atherosclerosis. Federation of American Societies for Experimental Biology 2013-04 /pmc/articles/PMC3606528/ /pubmed/23303209 http://dx.doi.org/10.1096/fj.12-219105 Text en © FASEB This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/us/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Communications
Kipari, Tiina
Hadoke, Patrick W. F.
Iqbal, Javaid
Man, Tak-Yung
Miller, Eileen
Coutinho, Agnes E.
Zhang, Zhenguang
Sullivan, Katie M.
Mitic, Tijana
Livingstone, Dawn E. W.
Schrecker, Christopher
Samuel, Kay
White, Christopher I.
Bouhlel, M. Amine
Chinetti-Gbaguidi, Giulia
Staels, Bart
Andrew, Ruth
Walker, Brian R.
Savill, John S.
Chapman, Karen E.
Seckl, Jonathan R.
11β-hydroxysteroid dehydrogenase type 1 deficiency in bone marrow-derived cells reduces atherosclerosis
title 11β-hydroxysteroid dehydrogenase type 1 deficiency in bone marrow-derived cells reduces atherosclerosis
title_full 11β-hydroxysteroid dehydrogenase type 1 deficiency in bone marrow-derived cells reduces atherosclerosis
title_fullStr 11β-hydroxysteroid dehydrogenase type 1 deficiency in bone marrow-derived cells reduces atherosclerosis
title_full_unstemmed 11β-hydroxysteroid dehydrogenase type 1 deficiency in bone marrow-derived cells reduces atherosclerosis
title_short 11β-hydroxysteroid dehydrogenase type 1 deficiency in bone marrow-derived cells reduces atherosclerosis
title_sort 11β-hydroxysteroid dehydrogenase type 1 deficiency in bone marrow-derived cells reduces atherosclerosis
topic Research Communications
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3606528/
https://www.ncbi.nlm.nih.gov/pubmed/23303209
http://dx.doi.org/10.1096/fj.12-219105
work_keys_str_mv AT kiparitiina 11bhydroxysteroiddehydrogenasetype1deficiencyinbonemarrowderivedcellsreducesatherosclerosis
AT hadokepatrickwf 11bhydroxysteroiddehydrogenasetype1deficiencyinbonemarrowderivedcellsreducesatherosclerosis
AT iqbaljavaid 11bhydroxysteroiddehydrogenasetype1deficiencyinbonemarrowderivedcellsreducesatherosclerosis
AT mantakyung 11bhydroxysteroiddehydrogenasetype1deficiencyinbonemarrowderivedcellsreducesatherosclerosis
AT millereileen 11bhydroxysteroiddehydrogenasetype1deficiencyinbonemarrowderivedcellsreducesatherosclerosis
AT coutinhoagnese 11bhydroxysteroiddehydrogenasetype1deficiencyinbonemarrowderivedcellsreducesatherosclerosis
AT zhangzhenguang 11bhydroxysteroiddehydrogenasetype1deficiencyinbonemarrowderivedcellsreducesatherosclerosis
AT sullivankatiem 11bhydroxysteroiddehydrogenasetype1deficiencyinbonemarrowderivedcellsreducesatherosclerosis
AT mitictijana 11bhydroxysteroiddehydrogenasetype1deficiencyinbonemarrowderivedcellsreducesatherosclerosis
AT livingstonedawnew 11bhydroxysteroiddehydrogenasetype1deficiencyinbonemarrowderivedcellsreducesatherosclerosis
AT schreckerchristopher 11bhydroxysteroiddehydrogenasetype1deficiencyinbonemarrowderivedcellsreducesatherosclerosis
AT samuelkay 11bhydroxysteroiddehydrogenasetype1deficiencyinbonemarrowderivedcellsreducesatherosclerosis
AT whitechristopheri 11bhydroxysteroiddehydrogenasetype1deficiencyinbonemarrowderivedcellsreducesatherosclerosis
AT bouhlelmamine 11bhydroxysteroiddehydrogenasetype1deficiencyinbonemarrowderivedcellsreducesatherosclerosis
AT chinettigbaguidigiulia 11bhydroxysteroiddehydrogenasetype1deficiencyinbonemarrowderivedcellsreducesatherosclerosis
AT staelsbart 11bhydroxysteroiddehydrogenasetype1deficiencyinbonemarrowderivedcellsreducesatherosclerosis
AT andrewruth 11bhydroxysteroiddehydrogenasetype1deficiencyinbonemarrowderivedcellsreducesatherosclerosis
AT walkerbrianr 11bhydroxysteroiddehydrogenasetype1deficiencyinbonemarrowderivedcellsreducesatherosclerosis
AT savilljohns 11bhydroxysteroiddehydrogenasetype1deficiencyinbonemarrowderivedcellsreducesatherosclerosis
AT chapmankarene 11bhydroxysteroiddehydrogenasetype1deficiencyinbonemarrowderivedcellsreducesatherosclerosis
AT seckljonathanr 11bhydroxysteroiddehydrogenasetype1deficiencyinbonemarrowderivedcellsreducesatherosclerosis